The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
250 jobs Number of planned job losses
Announcement Date
20 November 2008
Employment effect (start)
Foreseen end date
Description
AstraZeneca, a pharmaceutical company, has announced that it is to cut 250 jobs from its plant in Macclesfield in Cheshire. The cuts come as part of the company’s plans restructure sites across Europe over the next five years, with Belgium, Spain and Sweden also being affected, although as of 23 November 2008 it is not known when the jobs in Macclesfield will be lost. The company said the cuts were an attempt to improve its supply chain by introducing a regional packing strategy.
Sources
20 November 2008: Financial Times
20 November 2008: The Guardian
20 November 2008: BBC News
Citation
Eurofound (2008), Astra Zeneca, Internal restructuring in United Kingdom, factsheet number 67426, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67426.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
